Vemurafenib-Induced Radiation Recall Dermatitis: Case Report and Review of the Literature

Dermatology ◽  
2014 ◽  
Vol 230 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Katrin Conen ◽  
Katarzyna Mosna-Firlejczyk ◽  
Christoph Rochlitz ◽  
Andreas Wicki ◽  
Peter Itin ◽  
...  
2010 ◽  
Vol 10 (5) ◽  
pp. 404-406 ◽  
Author(s):  
A. Gabriella Wernicke ◽  
Alexander J. Swistel ◽  
Bhupesh Parashar ◽  
Patricia L. Myskowski

2020 ◽  
Vol 14 ◽  
Author(s):  
Wiliam T Tran ◽  
Carolina Ibáñez ◽  
Mauricio P Pinto ◽  
Cesar Sánchez ◽  
Gregory J Czarnota ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Keyur Mehta ◽  
Andreas Kaubisch ◽  
Justin Tang ◽  
Aneesh Pirlamarla ◽  
Shalom Kalnicki

Introduction. Radiation recall dermatitis (RRD) is a phenomenon that occurs in previously irradiated areas shortly after administration of a chemotherapeutic agent. As the use of sorafenib expands, the incidence of radiation recall dermatitis induced by sorafenib will likely increase. Here, we report on a patient who developed RRD and describe his clinical characteristics along with a review of the literature. Case Presentation. Our patient was treated with palliative radiation therapy (RT) to a painful metastatic hepatocellular carcinoma lesion in the right forearm. He completed his radiation course with grade 1 dermatitis, which had resolved by the time he was started on sorafenib 400 mg twice daily 7 days afterwards. On the 21st day after RT, he presented with desquamation and erythema in the previously irradiated area of the right forearm, consistent with RRD. The sorafenib was discontinued and his symptoms subsequently resolved with conservative topical management. Conclusions. Although the pathophysiologic mechanism of sorafenib-related radiation recall dermatitis remains to be investigated, practitioners should be aware of its presence and management in order to improve clinical outcomes.


2001 ◽  
Vol 87 (6) ◽  
pp. 428-430 ◽  
Author(s):  
Gil Bar-Sela ◽  
Alexander Beny ◽  
Reuven Bergman ◽  
Abraham Kuten

A 65-year-old male with lung adenocarcinoma received radiotherapy to the mediastinum and right upper lobe, followed by chemotherapy with gemcitabine. Radiation recall dermatitis developed in the area corresponding to the radiotherapy portal. This is one of just a few cases reported recently concerning radiation recall dermatitis stemming from gemcitabine.


2016 ◽  
Vol 11 (5) ◽  
pp. 3071-3074 ◽  
Author(s):  
MAMIKO UBUKATA ◽  
TAKAKO KAMIO ◽  
TETSUYA OHCHI ◽  
EIICHIRO NOGUCHI ◽  
HIROKO TSUKADA ◽  
...  

2019 ◽  
Vol 3 ◽  
pp. 39-39
Author(s):  
Fang-Yi Lin ◽  
Tung-Hao Chang ◽  
Chia-Chun Huang ◽  
Li-Chung Hung ◽  
Tsai-Wei Chou ◽  
...  

2016 ◽  
Vol 8 (12) ◽  
pp. E1589-E1593 ◽  
Author(s):  
Jin Ge ◽  
Vivek Verma ◽  
Andrew Hollander ◽  
Corey Langer ◽  
Charles B. Simone II

Sign in / Sign up

Export Citation Format

Share Document